Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1
Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 operates in Diversified Metals & Mining.
Market Cap & Net Worth: Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 (007575)
Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 (KQ:007575) has a market capitalization of $86.81K (₩127.10 Million) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #41335 globally and #2281 in its home market, demonstrating a 3.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1's stock price ₩12980.00 by its total outstanding shares 9792 (9.79K).
Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 Market Cap History: 2015 to 2025
Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1's market capitalization history from 2015 to 2025. Data shows change from $211.26K to $86.81K (-9.51% CAGR).
Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 007575 by Market Capitalization
Companies near Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 in the global market cap rankings as of March 19, 2026.
Key companies related to Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2400 globally with a market cap of $6.13 Billion USD ( €5.98 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2412 globally with a market cap of $6.09 Billion USD ( €5.94 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2400 | BERKSHIRE HATH-A | BE:BRH | $6.13 Billion | €634500.00 |
| #2412 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.09 Billion | €638000.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 Historical Marketcap From 2015 to 2025
Between 2015 and today, Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1's market cap moved from $211.26K to $ 86.81K, with a yearly change of -9.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩86.81K | +25.05% |
| 2024 | ₩69.42K | -37.24% |
| 2023 | ₩110.61K | -20.75% |
| 2022 | ₩139.58K | -26.01% |
| 2021 | ₩188.66K | -63.77% |
| 2020 | ₩520.75K | +363.34% |
| 2019 | ₩112.39K | -4.94% |
| 2018 | ₩118.24K | -28.32% |
| 2017 | ₩164.95K | +1.59% |
| 2016 | ₩162.37K | -23.14% |
| 2015 | ₩211.26K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Il-Yang Pharmaceutical Co. Ltd. Pfd. Series 1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $86.81K USD |
| MoneyControl | $86.81K USD |
| MarketWatch | $86.81K USD |
| marketcap.company | $86.81K USD |
| Reuters | $86.81K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.